HIV
News
Out-of-pocket costs put HIV prevention drug out of reach for many at risk
Since Truvada was approved for HIV prevention six years ago, its average wholesale price has increased by about 45 percent. Now, the drug carries...
Pharmacology
Tedizolid Use in Immunocompromised Patients
Conference Coverage
MicroRNAs flag liver damage in HIV-, HCV-infected persons
MicroRNAs are associated with elevated liver enzymes and fibrosis in HIV, HCV infection.
News
Repurposing With a Purpose
Researchers look to repurpose and reposition drugs to reduce the rate of infectious diseases contracted by patients with HIV/...
News
HCV incidence is elevated in HIV-positive MSM
Pharmacology
HIV Update: Which Single-Tablet Regimens, and When
With the approval of single-tablet regimens that contain 3 or 4 drugs, many patients take just 1 pill a day. So what are the options and what’s on...
Clinical Review
Open Clinical Trials for Patients With HIV and/or Hepatitis B and C
The primary objective of this study is to implement and evaluate a web-based brief alcohol intervention (BAI) for treating veterans with hepatitis...
News
Study Reaffirms Tenofovir’s Safety for Pregnant Women
Combination treatments containing tenofovir disoproxil fumarate are safe for pregnant women with HIV—again.
Conference Coverage
CKD triples risk of bad outcomes in HIV
BOSTON – Smoking, diabetes, dyslipidemia, low body mass index, and poor HIV control were modifiable risk factors for CKD.
News
What Ascites Might Mean in a Patient With HIV
A patient with HIV who recently experienced a renal cadaveric transplant showed signs of ascities, but clinicians found something else....